Medtronic Cardiac Surgery PMCF Registry
Launched by MEDTRONIC CARDIAC SURGERY · Aug 28, 2019
Trial Information
Current as of August 23, 2025
Recruiting
Keywords
ClinConnect Summary
The Medtronic Cardiac Surgery PMCF Registry is a study designed to gather information about patients who have valve disease or are undergoing heart surgery. The goal of this registry is to monitor the safety and effectiveness of certain medical devices used in these treatments after they have been approved for use. Researchers are currently looking for participants to join the study, and anyone can participate regardless of gender.
To be eligible, patients must give written consent to take part and either have already received or be planning to receive a specific medical device related to their heart condition. Participants should be available for follow-up visits, and they cannot be involved in other studies that might interfere with the results. If you join this registry, you can expect to share your experiences with the treatment and receive regular check-ins from the research team to monitor your progress and health outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
- • 2. Patient has or is intended to receive or be treated with an eligible product
- • 3. Patient is within enrollment window of treatment/therapy received at the time of their initial Registry enrollment, or meets criteria for retrospective enrollment
- Exclusion Criteria:
- • 1. Patient who is, or is expected to be, inaccessible for follow-up
- • 2. Patient prohibited from participation by local law
- • 3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or device study that may confound results
About Medtronic Cardiac Surgery
Medtronic Cardiac Surgery is a leading global sponsor dedicated to advancing innovative solutions in cardiac care. With a focus on enhancing patient outcomes and surgical efficacy, Medtronic develops cutting-edge medical devices and technologies that address complex cardiovascular conditions. The organization is committed to rigorous clinical research and trials, ensuring that its products meet the highest standards of safety and efficacy. By collaborating with healthcare professionals and institutions worldwide, Medtronic Cardiac Surgery aims to transform the landscape of cardiac surgery, ultimately improving the quality of life for patients around the globe.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
New York, New York, United States
Durham, North Carolina, United States
Marietta, Georgia, United States
Roslyn, New York, United States
Cleveland, Ohio, United States
Leiden, , Netherlands
Düsseldorf, , Germany
Athens, , Greece
Leuven, , Belgium
Pittsburgh, Pennsylvania, United States
Pessac, , France
Bern, , Switzerland
Leipzig, , Germany
Dresden, , Germany
Bad Rothenfelde, , Germany
Houston, Texas, United States
Falls Church, Virginia, United States
München, , Germany
Wien, , Austria
Plano, Texas, United States
Hamburg, , Germany
Massa, , Italy
San Donato, , Italy
Syracuse, New York, United States
Málaga, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials